Psoriasis
Not recruitingORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis
ORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis
Germany- Participants:18–64 years · 65+ years
- Substances:ORKA-001
- Sponsor:Oruka Therapeutics Inc.
Rare diseases
Investigational molecules
Locations
Back to Germany1 035 clinical trials in Coesfeld, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)ORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis
GermanyRO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes
GermanyEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
GermanyA study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
GermanyA study to evaluate the safety and effectiveness of galvokimig in adults with moderate to severe atopic dermatitis
GermanyA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
GermanyStudy of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
GermanyA study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia
GermanyA study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
GermanyA Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread
GermanyA Study of KT-621 Tablets Taken by Mouth for Adults with Moderate to Severe Atopic Dermatitis
GermanyA study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on respiratory distress syndrome in preterm infants, evaluating advanced treatment approaches to improve long-term pulmonary outcomes.
Research aims to optimize pulmonary function in premature infants through comparative studies of prophylactic versus selective treatment approaches, with a particular focus on long-term respiratory outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.